A REVIEW OF LINK ALTERNATIF MBL77

Not all sufferers with CLL have to have therapy. In spite of all the latest innovations, the iwCLL nonetheless suggests watchful observation for sufferers with asymptomatic illness.86 This advice is based on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC